Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease DOI Creative Commons
Martijn P. T. Ernst, Mike Broeders,

Pablo Herrero-Hernandez

et al.

Molecular Therapy — Methods & Clinical Development, Journal Year: 2020, Volume and Issue: 18, P. 532 - 557

Published: July 4, 2020

We present an overview of clinical trials involving gene editing using clustered interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), or zinc finger (ZFNs) and discuss the underlying mechanisms. In cancer immunotherapy, is applied ex vivo in T cells, transgenic cell receptor (tTCR)-T chimeric antigen (CAR)-T cells to improve adoptive therapy for multiple types. This involves knockouts immune checkpoint regulators such as PD-1, components endogenous TCR histocompatibility leukocyte (HLA) complex generate universal allogeneic CAR-T CD7 prevent self-destruction therapy. cervix carcinoma caused by human papillomavirus (HPV), E6 E7 genes are disrupted topically machinery. HIV infection, CCR5 co-receptor HIV-resistant hematopoietic stem cells. β-thalassemia sickle disease, engineered induce production fetal hemoglobin. AAV-mediated exploit liver systemic therapeutic proteins hemophilia mucopolysaccharidoses, eye restore splicing CEP920 Leber's congenital amaurosis. Close consideration safety aspects education stakeholders will be essential a successful implementation technology clinic.

Language: Английский

Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors DOI
Andrew V. Anzalone, Luke W. Koblan, David R. Liu

et al.

Nature Biotechnology, Journal Year: 2020, Volume and Issue: 38(7), P. 824 - 844

Published: June 22, 2020

Language: Английский

Citations

1787

CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors DOI Creative Commons
Dan Wang, Feng Zhang, Guangping Gao

et al.

Cell, Journal Year: 2020, Volume and Issue: 181(1), P. 136 - 150

Published: April 1, 2020

Language: Английский

Citations

393

High-content CRISPR screening DOI Open Access
Christoph Bock, Paul Datlinger, Florence M. Chardon

et al.

Nature Reviews Methods Primers, Journal Year: 2022, Volume and Issue: 2(1)

Published: Feb. 10, 2022

Language: Английский

Citations

371

The emerging and uncultivated potential of CRISPR technology in plant science DOI
Yingxiao Zhang, Aimee A. Malzahn, Simon Sretenovic

et al.

Nature Plants, Journal Year: 2019, Volume and Issue: 5(8), P. 778 - 794

Published: July 15, 2019

Language: Английский

Citations

336

Precise plant genome editing using base editors and prime editors DOI
Kutubuddin A. Molla, Simon Sretenovic, K. C. Bansal

et al.

Nature Plants, Journal Year: 2021, Volume and Issue: 7(9), P. 1166 - 1187

Published: Sept. 13, 2021

Language: Английский

Citations

253

CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy DOI Creative Commons
Yuanyuan Xu, Zhanjun Li

Computational and Structural Biotechnology Journal, Journal Year: 2020, Volume and Issue: 18, P. 2401 - 2415

Published: Jan. 1, 2020

Genome editing is the modification of genomic DNA at a specific target site in wide variety cell types and organisms, including insertion, deletion replacement DNA, resulting inactivation genes, acquisition novel genetic traits correction pathogenic gene mutations. Due to advantages simple design, low cost, high efficiency, good repeatability short-cycle, CRISPR-Cas systems have become most widely used genome technology molecular biology laboratories all around world. In this review, an overview will be introduced, innovations, applications human disease research therapy, as well challenges opportunities that faced practical application systems.

Language: Английский

Citations

240

Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning DOI Creative Commons
Mandana Arbab, Max W. Shen, Beverly Mok

et al.

Cell, Journal Year: 2020, Volume and Issue: 182(2), P. 463 - 480.e30

Published: June 12, 2020

Language: Английский

Citations

226

Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering DOI Creative Commons
Naoki Wada,

Risa Ueta,

Yuriko Osakabe

et al.

BMC Plant Biology, Journal Year: 2020, Volume and Issue: 20(1)

Published: May 25, 2020

Abstract Traditionally, generation of new plants with improved or desirable features has relied on laborious and time-consuming breeding techniques. Genome-editing technologies have led to a era genome engineering, enabling an effective, precise, rapid engineering the plant genomes. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (CRISPR/Cas9) emerged as genome-editing tool, extensively applied in various organisms, including plants. The use CRISPR/Cas9 allows generating transgene-free genome-edited (“null segregants”) period time. In this review, we provide critical overview recent advances derived for inducing mutations at target sites controlling expression genes. We highlight major breakthroughs applying challenges toward production null segregants. also update efforts Cas9 proteins, newly discovered variants, novel CRISPR/Cas systems application related will not only facilitate molecular crop but accelerate progress basic research.

Language: Английский

Citations

218

Understanding sheath blight resistance in rice: the road behind and the road ahead DOI Creative Commons
Kutubuddin A. Molla, Subhasis Karmakar,

Johiruddin Molla

et al.

Plant Biotechnology Journal, Journal Year: 2019, Volume and Issue: 18(4), P. 895 - 915

Published: Dec. 7, 2019

Rice sheath blight disease, caused by the basidiomycetous necrotroph Rhizoctonia solani, became one of major threats to rice cultivation worldwide, especially after adoption high-yielding varieties. The pathogen is challenging manage because its extensively broad host range and high genetic variability also due inability find any satisfactory level natural resistance from available germplasm. It time remedies combat for reducing yield losses subsequently minimize threat global food security. development alternative means avoid use hazardous chemical fungicides. This review mainly focuses on effort better understanding host-pathogen relationship, finding gene loci/markers imparting response modifying genome through transgenic development. latest trend in R. solani-rice pathosystem research with gap analysis are provided.

Language: Английский

Citations

210

High-content CRISPR screening DOI
Christoph Bock, Paul Datlinger, Florence M. Chardon

et al.

Nature Reviews Methods Primers, Journal Year: 2022, Volume and Issue: 2(1)

Published: Feb. 10, 2022

Language: Английский

Citations

204